TVS Srichakra Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 28, 2025, 9:46 am

Competitors of TVS Srichakra Ltd

All Competitor Stocks of TVS Srichakra Ltd

Quarterly Result

Last Updated: August 20, 2025, 1:55 am

Below is a detailed analysis of the quarterly data for TVS Srichakra Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 819.00 Cr.. The value appears strong and on an upward trend. It has increased from 818.00 Cr. (Mar 2025) to 819.00 Cr., marking an increase of 1.00 Cr..
• For Expenses, as of Jun 2025, the value is 771.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 752.00 Cr. (Mar 2025) to 771.00 Cr., marking an increase of 19.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 48.00 Cr.. The value appears to be declining and may need further review. It has decreased from 67.00 Cr. (Mar 2025) to 48.00 Cr., marking a decrease of 19.00 Cr..
• For OPM %, as of Jun 2025, the value is 6.00%. The value appears to be declining and may need further review. It has decreased from 8.00% (Mar 2025) to 6.00%, marking a decrease of 2.00%.
• For Other Income, as of Jun 2025, the value is 20.00 Cr.. The value appears strong and on an upward trend. It has increased from -3.00 Cr. (Mar 2025) to 20.00 Cr., marking an increase of 23.00 Cr..
• For Interest, as of Jun 2025, the value is 14.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 14.00 Cr..
• For Depreciation, as of Jun 2025, the value is 34.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 37.00 Cr. (Mar 2025) to 34.00 Cr., marking a decrease of 3.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 20.00 Cr.. The value appears strong and on an upward trend. It has increased from 12.00 Cr. (Mar 2025) to 20.00 Cr., marking an increase of 8.00 Cr..
• For Tax %, as of Jun 2025, the value is 36.00%. The value appears to be increasing, which may not be favorable. It has increased from 22.00% (Mar 2025) to 36.00%, marking an increase of 14.00%.
• For Net Profit, as of Jun 2025, the value is 13.00 Cr.. The value appears strong and on an upward trend. It has increased from 10.00 Cr. (Mar 2025) to 13.00 Cr., marking an increase of 3.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 16.82. The value appears strong and on an upward trend. It has increased from 12.52 (Mar 2025) to 16.82, marking an increase of 4.30.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: November 15, 2025, 4:14 am

Growth

Last Updated: September 5, 2025, 1:50 pm

Balance Sheet

Last Updated: September 10, 2025, 2:43 pm

Below is a detailed analysis of the balance sheet data for TVS Srichakra Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 8.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 8.00 Cr..
• For Reserves, as of Mar 2025, the value is 1,176.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,104.00 Cr. (Mar 2024) to 1,176.00 Cr., marking an increase of 72.00 Cr..
• For Borrowings, as of Mar 2025, the value is 886.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 842.00 Cr. (Mar 2024) to 886.00 Cr., marking an increase of 44.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 906.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 739.00 Cr. (Mar 2024) to 906.00 Cr., marking an increase of 167.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 2,976.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,694.00 Cr. (Mar 2024) to 2,976.00 Cr., marking an increase of 282.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 1,167.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,084.00 Cr. (Mar 2024) to 1,167.00 Cr., marking an increase of 83.00 Cr..
• For CWIP, as of Mar 2025, the value is 98.00 Cr.. The value appears to be declining and may need further review. It has decreased from 143.00 Cr. (Mar 2024) to 98.00 Cr., marking a decrease of 45.00 Cr..
• For Investments, as of Mar 2025, the value is 392.00 Cr.. The value appears strong and on an upward trend. It has increased from 260.00 Cr. (Mar 2024) to 392.00 Cr., marking an increase of 132.00 Cr..
• For Other Assets, as of Mar 2025, the value is 1,319.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,207.00 Cr. (Mar 2024) to 1,319.00 Cr., marking an increase of 112.00 Cr..
• For Total Assets, as of Mar 2025, the value is 2,976.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,694.00 Cr. (Mar 2024) to 2,976.00 Cr., marking an increase of 282.00 Cr..

Notably, the Reserves (1,176.00 Cr.) exceed the Borrowings (886.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for TVS Srichakra Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 26.92. This value is within the healthy range. It has decreased from 140.98 (Mar 24) to 26.92, marking a decrease of 114.06.
• For Diluted EPS (Rs.), as of Mar 25, the value is 26.92. This value is within the healthy range. It has decreased from 140.98 (Mar 24) to 26.92, marking a decrease of 114.06.
• For Cash EPS (Rs.), as of Mar 25, the value is 194.88. This value is within the healthy range. It has decreased from 276.23 (Mar 24) to 194.88, marking a decrease of 81.35.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 1,545.56. It has increased from 1,450.99 (Mar 24) to 1,545.56, marking an increase of 94.57.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 1,545.56. It has increased from 1,450.99 (Mar 24) to 1,545.56, marking an increase of 94.57.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 4,247.82. It has increased from 3,819.84 (Mar 24) to 4,247.82, marking an increase of 427.98.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 301.31. This value is within the healthy range. It has decreased from 396.13 (Mar 24) to 301.31, marking a decrease of 94.82.
• For PBIT / Share (Rs.), as of Mar 25, the value is 133.21. This value is within the healthy range. It has decreased from 260.59 (Mar 24) to 133.21, marking a decrease of 127.38.
• For PBT / Share (Rs.), as of Mar 25, the value is 47.66. This value is within the healthy range. It has decreased from 190.61 (Mar 24) to 47.66, marking a decrease of 142.95.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 26.79. This value is within the healthy range. It has decreased from 140.68 (Mar 24) to 26.79, marking a decrease of 113.89.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 26.91. This value is within the healthy range. It has decreased from 140.93 (Mar 24) to 26.91, marking a decrease of 114.02.
• For PBDIT Margin (%), as of Mar 25, the value is 7.09. This value is below the healthy minimum of 10. It has decreased from 10.37 (Mar 24) to 7.09, marking a decrease of 3.28.
• For PBIT Margin (%), as of Mar 25, the value is 3.13. This value is below the healthy minimum of 10. It has decreased from 6.82 (Mar 24) to 3.13, marking a decrease of 3.69.
• For PBT Margin (%), as of Mar 25, the value is 1.12. This value is below the healthy minimum of 10. It has decreased from 4.99 (Mar 24) to 1.12, marking a decrease of 3.87.
• For Net Profit Margin (%), as of Mar 25, the value is 0.63. This value is below the healthy minimum of 5. It has decreased from 3.68 (Mar 24) to 0.63, marking a decrease of 3.05.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 0.63. This value is below the healthy minimum of 8. It has decreased from 3.68 (Mar 24) to 0.63, marking a decrease of 3.05.
• For Return on Networth / Equity (%), as of Mar 25, the value is 1.74. This value is below the healthy minimum of 15. It has decreased from 9.70 (Mar 24) to 1.74, marking a decrease of 7.96.
• For Return on Capital Employeed (%), as of Mar 25, the value is 6.11. This value is below the healthy minimum of 10. It has decreased from 12.04 (Mar 24) to 6.11, marking a decrease of 5.93.
• For Return On Assets (%), as of Mar 25, the value is 0.69. This value is below the healthy minimum of 5. It has decreased from 4.00 (Mar 24) to 0.69, marking a decrease of 3.31.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.29. This value is within the healthy range. It has decreased from 0.38 (Mar 24) to 0.29, marking a decrease of 0.09.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.74. This value is within the healthy range. It has decreased from 0.75 (Mar 24) to 0.74, marking a decrease of 0.01.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.15. It has increased from 1.14 (Mar 24) to 1.15, marking an increase of 0.01.
• For Current Ratio (X), as of Mar 25, the value is 0.92. This value is below the healthy minimum of 1.5. It has decreased from 1.06 (Mar 24) to 0.92, marking a decrease of 0.14.
• For Quick Ratio (X), as of Mar 25, the value is 0.31. This value is below the healthy minimum of 1. It has decreased from 0.38 (Mar 24) to 0.31, marking a decrease of 0.07.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 4.33. This value is within the healthy range. It has increased from 2.10 (Mar 24) to 4.33, marking an increase of 2.23.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 175.88. This value exceeds the healthy maximum of 50. It has increased from 22.73 (Mar 24) to 175.88, marking an increase of 153.15.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 24.26. This value is within the healthy range. It has increased from 11.58 (Mar 24) to 24.26, marking an increase of 12.68.
• For Earning Retention Ratio (%), as of Mar 25, the value is -75.88. This value is below the healthy minimum of 40. It has decreased from 77.27 (Mar 24) to -75.88, marking a decrease of 153.15.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 75.74. This value exceeds the healthy maximum of 70. It has decreased from 88.42 (Mar 24) to 75.74, marking a decrease of 12.68.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 4.26. This value is within the healthy range. It has decreased from 6.80 (Mar 24) to 4.26, marking a decrease of 2.54.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.59. This value is below the healthy minimum of 3. It has decreased from 3.61 (Mar 24) to 1.59, marking a decrease of 2.02.
• For Enterprise Value (Cr.), as of Mar 25, the value is 2,801.98. It has decreased from 3,806.93 (Mar 24) to 2,801.98, marking a decrease of 1,004.95.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.86. This value is below the healthy minimum of 1. It has decreased from 1.30 (Mar 24) to 0.86, marking a decrease of 0.44.
• For EV / EBITDA (X), as of Mar 25, the value is 12.14. This value is within the healthy range. It has decreased from 12.55 (Mar 24) to 12.14, marking a decrease of 0.41.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.59. This value is below the healthy minimum of 1. It has decreased from 1.02 (Mar 24) to 0.59, marking a decrease of 0.43.
• For Retention Ratios (%), as of Mar 25, the value is -75.88. This value is below the healthy minimum of 30. It has decreased from 77.26 (Mar 24) to -75.88, marking a decrease of 153.14.
• For Price / BV (X), as of Mar 25, the value is 1.64. This value is within the healthy range. It has decreased from 2.69 (Mar 24) to 1.64, marking a decrease of 1.05.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.59. This value is below the healthy minimum of 1. It has decreased from 1.02 (Mar 24) to 0.59, marking a decrease of 0.43.
• For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. It has decreased from 0.03 (Mar 24) to 0.01, marking a decrease of 0.02.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness